Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts.

Adult Australia / epidemiology Birth Weight Body Mass Index Cohort Studies Europe / epidemiology Female Gestational Age Gestational Weight Gain / physiology Humans Infant, Newborn North America / epidemiology Odds Ratio Overweight / complications Pregnancy Pregnancy Complications / epidemiology Risk Factors
Birthweight body mass index pregnancy complications preterm birth weight gain

Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
Jul 2019
Historique:
accepted: 06 02 2019
pubmed: 21 2 2019
medline: 18 6 2019
entrez: 21 2 2019
Statut: ppublish

Résumé

To assess the separate and combined associations of maternal pre-pregnancy body mass index (BMI) and gestational weight gain with the risks of pregnancy complications and their population impact. Individual participant data meta-analysis of 39 cohorts. Europe, North America, and Oceania. 265 270 births. Information on maternal pre-pregnancy BMI, gestational weight gain, and pregnancy complications was obtained. Multilevel binary logistic regression models were used. Gestational hypertension, pre-eclampsia, gestational diabetes, preterm birth, small and large for gestational age at birth. Higher maternal pre-pregnancy BMI and gestational weight gain were, across their full ranges, associated with higher risks of gestational hypertensive disorders, gestational diabetes, and large for gestational age at birth. Preterm birth risk was higher at lower and higher BMI and weight gain. Compared with normal weight mothers with medium gestational weight gain, obese mothers with high gestational weight gain had the highest risk of any pregnancy complication (odds ratio 2.51, 95% CI 2.31- 2.74). We estimated that 23.9% of any pregnancy complication was attributable to maternal overweight/obesity and 31.6% of large for gestational age infants was attributable to excessive gestational weight gain. Maternal pre-pregnancy BMI and gestational weight gain are, across their full ranges, associated with risks of pregnancy complications. Obese mothers with high gestational weight gain are at the highest risk of pregnancy complications. Promoting a healthy pre-pregnancy BMI and gestational weight gain may reduce the burden of pregnancy complications and ultimately the risk of maternal and neonatal morbidity. Promoting a healthy body mass index and gestational weight gain might reduce the population burden of pregnancy complications.

Identifiants

DOI: 10.1111/1471-0528.15661 PMID: 30786138 PMC: PMC6554069
pubmed: 30786138
doi: 10.1111/1471-0528.15661
pmc: PMC6554069
mid: NIHMS1025132
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

984-995

Subventions

Organisme : British Heart Foundation
ID : RG/15/17/31749
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K006665/1
Pays : United Kingdom
Organisme : NIH HHS
ID : UH3 OD023286
Pays : United States
Organisme : Medical Research Council
ID : G0601712
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A620_1017
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : P30 DK092924
Pays : United States
Organisme : NIH HHS
ID : UG3 OD023286
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/14/33/30827
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K021656/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12013/5
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : R01 HD034568
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 Royal College of Obstetricians and Gynaecologists.

Références

BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Am J Epidemiol. 2004 Aug 15;160(4):331-8
pubmed: 15286018
BMJ. 2004 Sep 18;329(7467):675-8
pubmed: 15374920
Lancet. 2005 Mar 5-11;365(9462):891-900
pubmed: 15752534
Lancet. 2005 Oct 1;366(9492):1197-209
pubmed: 16198769
Epidemiology. 2006 Mar;17(2):170-7
pubmed: 16477257
Lancet. 2006 Sep 30;368(9542):1164-70
pubmed: 17011943
Paediatr Perinat Epidemiol. 2007 Jan;21(1):5-14
pubmed: 17239174
BMJ. 2007 Nov 10;335(7627):974
pubmed: 17975258
Am J Clin Nutr. 2008 Jun;87(6):1750-9
pubmed: 18541565
Lancet. 2009 May 23;373(9677):1773-9
pubmed: 19465232
BJOG. 2009 Jun;116(7):953-63
pubmed: 19522798
Acta Paediatr Scand. 1991 Aug-Sep;80(8-9):756-62
pubmed: 1957592
Lancet. 2010 Sep 18;376(9745):984-90
pubmed: 20691469
CMAJ. 2012 Aug 7;184(11):1265-9
pubmed: 22371511
PLoS One. 2013;8(1):e53749
pubmed: 23341993
Curr Opin Obstet Gynecol. 2013 Apr;25(2):124-32
pubmed: 23403779
Int J Epidemiol. 2013 Feb;42(1):7-29
pubmed: 23508404
PLoS One. 2013 Apr 09;8(4):e60650
pubmed: 23585842
JAMA. 2013 Jun 12;309(22):2362-70
pubmed: 23757084
Obesity (Silver Spring). 2013 May;21(5):1046-55
pubmed: 23784909
JAMA. 2014 Apr 16;311(15):1536-46
pubmed: 24737366
Obstet Gynecol. 2014 Apr;123(4):737-44
pubmed: 24785599
Paediatr Perinat Epidemiol. 2015 Jan;29(1):11-21
pubmed: 25492396
Obes Rev. 2015 Aug;16(8):621-38
pubmed: 26016557
Sci Rep. 2016 Mar 10;6:22895
pubmed: 26961675
JAMA. 2016 Mar 15;315(11):1129-40
pubmed: 26978208
Lancet Diabetes Endocrinol. 2016 Dec;4(12):1025-1036
pubmed: 27743975
Obes Rev. 2017 Mar;18(3):350-369
pubmed: 28170169
BMJ. 2017 Feb 8;356:j1
pubmed: 28179267
JAMA. 2017 Jun 6;317(21):2207-2225
pubmed: 28586887
BMJ. 2017 Jul 19;358:j3119
pubmed: 28724518
Aust N Z J Obstet Gynaecol. 2019 Jun;59(3):367-374
pubmed: 30024043
J Dev Orig Health Dis. 2018 Aug 16;:1-7
pubmed: 30111382
BMC Med. 2018 Nov 5;16(1):201
pubmed: 30396358
Clin Obstet Gynecol. 1976 Sep;19(3):489-513
pubmed: 954246

Auteurs

S Santos (S)

The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

E Voerman (E)

The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

P Amiano (P)

Public Health Division of Gipuzkoa, San Sebastián, Spain.
BioDonostia Research Institute, San Sebastián, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

H Barros (H)

EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
Department of Public Health and Forensic Sciences and Medical Education, Unit of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal.

L J Beilin (LJ)

Medical School, Royal Perth Hospital Unit, The University of Western Australia, Perth, WA, Australia.

A Bergström (A)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Centre for Occupational and Environmental Medicine, Stockholm County Council, Stockholm, Sweden.

M-A Charles (MA)

INSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), ORCHAD Team, Villejuif, France.
Paris Descartes University, Villejuif, France.

L Chatzi (L)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Faculty of Medicine, Department of Social Medicine, University of Crete, Heraklion, Greece.
Department of Genetics and Cell Biology, Maastricht University, Maastricht, the Netherlands.

C Chevrier (C)

Inserm UMR 1085, Irset - Research Institute for Environmental and Occupational Health, Rennes, France.

G P Chrousos (GP)

First Department of Pediatrics, Athens University Medical School, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.

E Corpeleijn (E)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

O Costa (O)

Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, Valencia, Spain.

N Costet (N)

Inserm UMR 1085, Irset - Research Institute for Environmental and Occupational Health, Rennes, France.

S Crozier (S)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.

G Devereux (G)

Liverpool School of Tropical Medicine, Liverpool, UK.

M Doyon (M)

Centre de Recherche du Centre Hospitalier de l'Universite de Sherbrooke, Sherbrooke, QC, Canada.

M Eggesbø (M)

Department of Exposure and Environmental Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.

M P Fantini (MP)

The Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

S Farchi (S)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

F Forastiere (F)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

V Georgiu (V)

Faculty of Medicine, Department of Social Medicine, University of Crete, Heraklion, Greece.

K M Godfrey (KM)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

D Gori (D)

The Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

V Grote (V)

Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children's Hospital, Ludwig-Maximilian-Universität Munich, Munich, Germany.

W Hanke (W)

Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.

I Hertz-Picciotto (I)

Department of Public Health Sciences, School of Medicine, University of California Davis, Davis, CA, USA.

B Heude (B)

INSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), ORCHAD Team, Villejuif, France.
Paris Descartes University, Villejuif, France.

M-F Hivert (MF)

Centre de Recherche du Centre Hospitalier de l'Universite de Sherbrooke, Sherbrooke, QC, Canada.
Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.

D Hryhorczuk (D)

Center for Global Health, University of Illinois College of Medicine, Chicago, IL, USA.

R-C Huang (RC)

Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia.

H Inskip (H)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

A M Karvonen (AM)

Department of Health Security, National Institute for Health and Welfare, Kuopio, Finland.

L C Kenny (LC)

Irish Centre for Fetal and Neonatal Translational Research, Cork University Maternity Hospital, University College Cork, Cork, Ireland.
Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork, Ireland.

B Koletzko (B)

Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children's Hospital, Ludwig-Maximilian-Universität Munich, Munich, Germany.

L K Küpers (LK)

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
MRC Integrative Epidemiology Unit, Oakfield House, Oakfield Grove, University of Bristol, Bristol, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.
Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.

H Lagström (H)

Department of Public Health, University of Turku, Turku, Finland.

I Lehmann (I)

Department of Environmental Immunology/Core Facility Studies, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.

P Magnus (P)

Division of Health Data and Digitalization, Norwegian Institute of Public Health, Oslo, Norway.

R Majewska (R)

Department of Epidemiology, Chair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Krakow, Poland.

J Mäkelä (J)

Turku Centre for Biotechnology, University of Turku and Abo Akademi University, Turku, Finland.

Y Manios (Y)

Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.

F M McAuliffe (FM)

UCD Perinatal Research Centre, Obstetrics& Gynaecology, School of Medicine, National Maternity Hospital, University College Dublin, Dublin, Ireland.

S W McDonald (SW)

Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

J Mehegan (J)

UCD Perinatal Research Centre, School of Public Health and Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.

E Melén (E)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Sach's Children Hospital, Stockholm, Sweden.

M Mommers (M)

Department of Epidemiology, Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands.

C S Morgen (CS)

National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.

G Moschonis (G)

Department of Rehabilitation, Nutrition and Sport, La Trobe University, Melbourne, Vic, Australia.

D Murray (D)

Irish Centre for Fetal and Neonatal Translational Research, Cork University Maternity Hospital, University College Cork, Cork, Ireland.
Paediatrics & Child Health, University College Cork, Cork, Ireland.

C Ní Chaoimh (C)

Irish Centre for Fetal and Neonatal Translational Research, Cork University Maternity Hospital, University College Cork, Cork, Ireland.
Cork Centre for Vitamin D and Nutrition Research, School of Food and Nutritional Sciences, University College Cork, Cork, Ireland.

E A Nohr (EA)

Research Unit for Gynaecology and Obstetrics, Institute for Clinical Research, University of Southern Denmark, Odense, Denmark.

A-M Nybo Andersen (AM)

Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.

E Oken (E)

Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.

Ajjm Oostvogels (A)

Department of Public Health, Amsterdam Public Health Research Institute, Academic Medical Center, Amsterdam, the Netherlands.

A Pac (A)

Department of Epidemiology, Chair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Krakow, Poland.

E Papadopoulou (E)

Department of Environmental Exposures and Epidemiology, Domain of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.

J Pekkanen (J)

Department of Health Security, National Institute for Health and Welfare, Kuopio, Finland.
Department of Public Health, University of Helsinki, Helsinki, Finland.

C Pizzi (C)

Department of Medical Sciences, University of Turin, Turin, Italy.

K Polanska (K)

Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.

D Porta (D)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

L Richiardi (L)

Department of Medical Sciences, University of Turin, Turin, Italy.

S L Rifas-Shiman (SL)

Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.

N Roeleveld (N)

Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

L Ronfani (L)

Institute for Maternal and Child Health - IRCCS 'Burlo Garofolo', Trieste, Italy.

A C Santos (AC)

EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
Department of Public Health and Forensic Sciences and Medical Education, Unit of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal.

M Standl (M)

Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.

H Stigum (H)

Department of Non-communicable Diseases, Norwegian Institute of Public Health, Oslo, Norway.

C Stoltenberg (C)

Norwegian Institute of Public Health, Oslo, Norway.
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

E Thiering (E)

Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

C Thijs (C)

Department of Epidemiology, Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands.

M Torrent (M)

Ib-salut, Area de Salut de Menorca, Menorca, Spain.

S C Tough (SC)

Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

T Trnovec (T)

Department of Environmental Medicine, Slovak Medical University, Bratislava, Slovak Republic.

S Turner (S)

Child Health, Royal Aberdeen Children's Hospital, Aberdeen, UK.

Mmhj van Gelder (M)

Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud REshape Innovation Center, Radboud University Medical Center, Nijmegen, the Netherlands.

L van Rossem (L)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

A von Berg (A)

Department of Pediatrics, Research Institute, Marien-Hospital Wesel, Wesel, Germany.

M Vrijheid (M)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
ISGlobal, Institute for Global Health, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Tgm Vrijkotte (T)

Department of Public Health, Amsterdam Public Health Research Institute, Academic Medical Center, Amsterdam, the Netherlands.

J West (J)

Bradford Institute for Health Research, Bradford Royal Infirmary, Bradford, UK.

A H Wijga (AH)

National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

J Wright (J)

Bradford Institute for Health Research, Bradford Royal Infirmary, Bradford, UK.

O Zvinchuk (O)

Department of Medical and Social Problems of Family Health, Institute of Pediatrics, Obstetrics and Gynecology, Kyiv, Ukraine.

Tia Sørensen (T)

Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
Section of Metabolic Genetics, Faculty of Health and Medical Sciences, The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.

D A Lawlor (DA)

MRC Integrative Epidemiology Unit, Oakfield House, Oakfield Grove, University of Bristol, Bristol, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.

R Gaillard (R)

The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Vwv Jaddoe (V)

The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Impact of maternal body mass index and...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Impact of maternal body mass index and...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Mensurations corporelles › Poids › Poids de naissance › Impact of maternal body mass index and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Biométrie › Anthropométrie › Indice de masse corporelle › Impact of maternal body mass index and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Impact of maternal body mass index and...
questionsmedicales.fr › Régions géographiques › Europe › Impact of maternal body mass index and...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Âge gestationnel › Impact of maternal body mass index and...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Prise de poids pendant la grossesse › Impact of maternal body mass index and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Impact of maternal body mass index and...
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Nouveau-né › Impact of maternal body mass index and...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › Impact of maternal body mass index and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Odds ratio › Impact of maternal body mass index and...
questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Apparence corporelle › Surpoids › Impact of maternal body mass index and...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Impact of maternal body mass index and...
questionsmedicales.fr › Maladies urogénitales › Maladies de l'appareil urogénital féminin et complications de la grossesse › Complications de la grossesse › Impact of maternal body mass index and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Impact of maternal body mass index and...